Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of rituximab + short systemic corticosteroid therapy versus long-duration systemic corticosteroid therapy in pemphigus
2008-005266-31Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pemphigus comparing Rituximab + short-course systemic corticosteroid therapy with Long-duration systemic corticosteroid therapy (2 arms). Primary endpoint: Complete remission off therapy at 24 months. Started Mar 2009; status: active.
02
Drugs
rituximabprednisone
03
Conditions
pemphigus
Beyond the preview
Go deeper on 2008-005266-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005266-31.